Solventum Corporation
SOLV
$70.40
-$0.41-0.58%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.33B | 8.40B | 8.39B | 8.31B | 8.25B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.33B | 8.40B | 8.39B | 8.31B | 8.25B |
| Cost of Revenue | 3.87B | 3.83B | 3.79B | 3.74B | 3.64B |
| Gross Profit | 4.46B | 4.57B | 4.60B | 4.56B | 4.61B |
| SG&A Expenses | 3.10B | 3.08B | 3.00B | 2.93B | 2.75B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.70B | 7.67B | 7.55B | 7.44B | 7.16B |
| Operating Income | 624.00M | 736.00M | 843.00M | 872.00M | 1.09B |
| Income Before Tax | 1.71B | 1.67B | 322.00M | 315.00M | 606.00M |
| Income Tax Expenses | 157.00M | 145.00M | -58.00M | -64.00M | 127.00M |
| Earnings from Continuing Operations | 1.56K | 1.52K | 380.00 | 379.00 | 479.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.56B | 1.52B | 380.00M | 379.00M | 479.00M |
| EBIT | 624.00M | 736.00M | 843.00M | 872.00M | 1.09B |
| EBITDA | 1.11B | 1.26B | 1.38B | 1.42B | 1.65B |
| EPS Basic | 8.93 | 8.75 | 2.19 | 2.19 | 2.77 |
| Normalized Basic EPS | 1.01 | 1.16 | 1.48 | 1.42 | 2.41 |
| EPS Diluted | 8.87 | 8.69 | 2.17 | 2.17 | 2.76 |
| Normalized Diluted EPS | 1.00 | 1.15 | 1.47 | 1.42 | 2.41 |
| Average Basic Shares Outstanding | 696.50M | 695.50M | 694.60M | 693.70M | 692.70M |
| Average Diluted Shares Outstanding | 701.10M | 699.90M | 698.40M | 696.70M | 694.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |